{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:13:32Z","timestamp":1773195212864,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We conducted an exploratory pilot feasibility study to assess the safety and feasibility of cardiopulmonary exercise testing (CPET) in patients with mild generalized myasthenia gravis (gMG), aiming to determine whether test termination results from systemic exertion or MG-specific neuromuscular fatigability and to evaluate short-term effects on fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Nine patients with mild gMG (median age of 58 years, IQR 46.0\u201366.5) were included in this exploratory feasibility study and underwent a single maximal incremental CPET on a cycle ergometer with breath-by-breath gas exchange analysis and blood lactate measurements. Predefined exertion criteria (EC) included respiratory exchange rate (RER; \u22651.1), ventilatory equivalent for O\n                      <jats:sub>2<\/jats:sub>\n                      (EQO\n                      <jats:sub>2<\/jats:sub>\n                      ; \u226530), attainment of age-related maximum heart rate (ARMHR), peak blood lactate concentration (&amp;gt;6 mmol\u00b7L\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), and Borg Scale for Rated Perceived Exertion (RPE; \u226517). Repetitive nerve stimulation (RNS) was performed before and after CPET to assess neuromuscular fatigability. Fatigue was assessed using the Chalder Fatigue Scale (CFS) at baseline and 4 weeks after CPET.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CPET was completed by all participants without adverse events. All reported symptoms resolved within 30 min after exercise termination, and no participant required medical intervention. All participants completed the maximal incremental CPET according to the predefined protocol. Among the predefined EC, 44% of participants achieved an RER \u22651.1, 78% an EQO\n                      <jats:sub>2<\/jats:sub>\n                      \u226530, 44% an ARMHR, 67% reached a peak blood lactate concentration &amp;gt;6 mmol\u00b7L\n                      <jats:sup>\u22121-<\/jats:sup>\n                      , and 67% an RPE \u226517. A decremental response in RNS was observed in 78% both before and after CPET. No relevant changes in CFS scores were detected over 4 weeks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>CPET appears safe and feasible in mild gMG, with exercise termination primarily driven by systemic exertion rather than MG-specific neuromuscular fatigue. CPET may complement clinical evaluation by supporting individualized training recommendations and the identification of cardiopulmonary limitations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphys.2026.1760707","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:31:42Z","timestamp":1773120702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study"],"prefix":"10.3389","volume":"17","author":[{"given":"Frauke","family":"Stascheit","sequence":"first","affiliation":[{"name":"Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin, Department of Neurology with Experimental Neurology","place":["Berlin, Germany"]},{"name":"Neuroscience Clinical Research Center, Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Lauermann","sequence":"additional","affiliation":[{"name":"University Outpatient Clinic for Sports Medicine and Sports Orthopedics, University of Potsdam","place":["Potsdam, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Risch","sequence":"additional","affiliation":[{"name":"University Outpatient Clinic for Sports Medicine and Sports Orthopedics, University of Potsdam","place":["Potsdam, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Mayer","sequence":"additional","affiliation":[{"name":"University Outpatient Clinic for Sports Medicine and Sports Orthopedics, University of Potsdam","place":["Potsdam, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin, Department of Neurology with Experimental Neurology","place":["Berlin, Germany"]},{"name":"Neuroscience Clinical Research Center, Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin, Department of Neurology with Experimental Neurology","place":["Berlin, Germany"]},{"name":"Neuroscience Clinical Research Center, Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Stroke Research Berlin, Charit\u00e9 \u2014 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Roecker","sequence":"additional","affiliation":[{"name":"Institute for Applied Health Promotion and Exercise Medicine (IfAG), Furtwangen University","place":["Furtwangen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cassel","sequence":"additional","affiliation":[{"name":"University Outpatient Clinic for Sports Medicine and Sports Orthopedics, University of Potsdam","place":["Potsdam, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B43","first-page":"64","article-title":"Likert scales and data analyses","volume":"40","author":"Allen","year":"2007","journal-title":"Quality Progress"},{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mus.23771","article-title":"Exercise in neuromuscular disease","volume":"48","author":"Anziska","year":"2013","journal-title":"Muscle Nerve"},{"key":"B2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/14779072.2021.2009802","article-title":"Cardiopulmonary exercise testing in neuromuscular disease: a systematic review","volume":"19","author":"Barroso de Queiroz Davoli","year":"2021","journal-title":"Expert Review Cardiovasc. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.nmd.2021.05.002","article-title":"Home-based exercise in autoimmune myasthenia gravis: a randomized controlled trial","volume":"31","author":"Birnbaum","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3390\/jcm14124190","article-title":"Cardiopulmonary recovery after maximal exercise in individuals with neuromuscular disease and limited mobility","volume":"14","author":"Blumberg","year":"2025","journal-title":"J. Clin. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med. Sci. Sports Exerc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1249\/JSR.0b013e31827dc211","article-title":"Myasthenia gravis and sports participation","volume":"12","author":"Cass","year":"2013","journal-title":"Curr. Sports Med. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jpsychores.2009.10.007","article-title":"Measuring fatigue in clinical and community settings","volume":"69","author":"Cella","year":"2010","journal-title":"J. Psychosom. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/ene.13867","article-title":"Sensitivity of MG-ADL for generalized weakness in myasthenia gravis","volume":"26","author":"de Meel","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2165\/00007256-200939060-00003","article-title":"Lactate threshold concepts: how valid are they?","volume":"39","author":"Faude","year":"2009","journal-title":"Sports Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nmd.2020.12.004","article-title":"Physical training and exercise in myasthenia gravis","volume":"31","author":"Gilhus","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12931-021-01895-6","article-title":"Practical guide to cardiopulmonary exercise testing in adults","volume":"23","author":"Glaab","year":"2022","journal-title":"Respir. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00538","DOI":"10.1002\/brb3.538","article-title":"Fatigue in myasthenia gravis: risk factors and impact on quality of life","volume":"6","author":"Hoffmann","year":"2016","journal-title":"Brain Behav."},{"key":"B16","first-page":"289","volume-title":"Spiroergometrie: kardiopulmonale Leistungsdiagnostik des Gesunden und Kranken","author":"Hollmann","year":"2006"},{"key":"B17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/acn3.51376","article-title":"Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses","volume":"8","author":"Howard","year":"","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1249\/00005768-199509000-00009","article-title":"Criteria for maximal oxygen uptake: review and commentary","volume":"27","author":"Howley","year":"1995","journal-title":"Med. Sci. Sports Exerc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.5455\/annalsmedres.2021.09.563","article-title":"The impact of aerobic exercise on fatigue, kinesiophobia and disease severity in myasthenia gravis patients","volume":"29","author":"Karaahmet","year":"2022","journal-title":"Ann. Med. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","article-title":"Burden of disease in myasthenia gravis: taking the patient's perspective","volume":"269","author":"Lehnerer","year":"2022","journal-title":"J. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol. Belg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fneur.2020.00675","article-title":"Myasthenia gravis and physical exercise: a novel paradigm","volume":"11","author":"O'Connor","year":"2020","journal-title":"Front. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e213781","DOI":"10.1212\/WNL.0000000000213781","article-title":"Efficacy of combined aerobic exercise and coaching on physical fitness in people with neuromuscular diseases: a randomized clinical trial","volume":"105","author":"Oorschot","year":"2025","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2011.05.028","article-title":"Cardiac autonomic control in patients with myasthenia gravis and thymoma","volume":"307","author":"Peric","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.nmd.2023.02.009","article-title":"Implementation of tailored exercise programs for MG patients in a gym setting: a pragmatic feasibility case study","volume":"33","author":"Punga","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.25552","article-title":"Exercise in myasthenia gravis: a feasibility study of aerobic and resistance training","volume":"56","author":"Rahbek","year":"2017","journal-title":"Muscle Nerve"},{"key":"B30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-2003-39087","article-title":"Heart-rate recommendations: transfer between running and cycling exercise?","volume":"24","author":"Roecker","year":"2003","journal-title":"Int. J. Sports Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1249\/MSS.0b013e3181935a11","article-title":"Time course of changes in endurance capacity: a 1-yr training study","volume":"41","author":"Scharhag-Rosenberger","year":"2009","journal-title":"Med. Sci. Sports Exerc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.autrev.2017.11.010","article-title":"Physical activity and autoimmune diseases: get moving and manage the disease","volume":"17","author":"Sharif","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0735-1097(00)01054-8","article-title":"Age-predicted maximal heart rate revisited","volume":"37","author":"Tanaka","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12890-022-02289-0","article-title":"Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease","volume":"22","author":"Tomlinson","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.apmr.2024.07.006","article-title":"Validity of cardiopulmonary exercise testing for assessing aerobic capacity in neuromuscular diseases","volume":"105","author":"Veneman","year":"2024","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105318","DOI":"10.1016\/j.nmd.2025.105318","article-title":"281st ENMC international workshop: 2nd ENMC workshop on exercise training in muscle diseases; towards consensus-based recommendations on exercise prescription and outcome measures. Hoofddorp, the Netherlands, 4-6 October 2024","volume":"49","author":"Voorn","year":"2025","journal-title":"Neuromuscul. Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"EVIDoa2100066","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evid."},{"key":"B38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/HCO.0000000000000437","article-title":"Health benefits of physical activity: a systematic review of current systematic reviews","volume":"32","author":"Warburton","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.nmd.2020.08.355","article-title":"Mortality rates and causes of death in Swedish myasthenia gravis patients","volume":"30","author":"Westerberg","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mus.25493","article-title":"Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: a pilot study","volume":"56","author":"Westerberg","year":"2017","journal-title":"Muscle Nerve"},{"key":"B41","article-title":"Diagnostik und Therapie myasthener Syndrome, S2k-Leitlinie, 2024, in: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"Wiendl","year":"2024"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/neurolint15030071","article-title":"Altered cardiac autonomic regulation in individuals with myasthenia Gravis-A systematic review and meta-analysis","volume":"15","author":"Zawadka-Kunikowska","year":"2023","journal-title":"Neurol. Int."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1760707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:31:43Z","timestamp":1773120703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1760707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":43,"alternative-id":["10.3389\/fphys.2026.1760707"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2026.1760707","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1760707"}}